Abbreviations used:AER ( absolute excess risk), CLL ( chronic lymphocytic leukemia), NHL ( non-Hodgkin lymphoma), PY ( person-years), SEER ( Surveillance, Epidemiology, and End Results), SIR ( standardized incidence ratio), UV ( ultraviolet)
Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al. SEER cancer statistics review, 1975-2006. Available from: URL: http://seer.cancer.gov/csr/1975_2006/. Accessed April 9, 2011.
- Solar radiation in the etiology of cutaneous malignant melanoma in Caucasians.Natl Cancer Inst Monogr. 1982; 62: 162-171
- Melanoma and exposure to sunlight.Epidemiol Rev. 1982; 4: 110-136
- Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenic types.J Natl Cancer Inst. 1984; 73: 75-82
- Risk factors for cutaneous malignant melanoma: the Western Canada melanoma study.in: Gallagher R.P. Epidemiology of malignant melanoma. Springer-Verlag, Berlin1986: 38-55
- Ambient UV, personal sun exposure and risk of multiple primary melanomas.Cancer Causes Control. 2007; 18: 295-304
- Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancer: vitamin D as a possible explanation.Eur J Cancer. 2007; 43: 1701-1712
- Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) program.Oncologist. 2007; 12: 20-37
- New malignancies following melanoma of the skin, eye melanoma, and non-melanoma eye cancer. SEER cancer registries, 1973-2000. NIH publication No. 05-5302.National Cancer Institute, Bethesda (MD)2006 (p. 339-62)
- Increased risk of second primary cancers after a diagnosis of melanoma.Arch Dermatol. 2010; 146: 265-272
- The risk of developing a second, different, cancer among 14560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian network of cancer registries).Melanoma Res. 2008; 18: 230-234
- Second primary cancers in patients with skin cancer: a population-based study in Northern Ireland.Br J Cancer. 2009; 100: 174-177
- Non-Hodgkin's lymphoma and skin malignancies–shared etiology?.Int J Cancer. 1995; 62: 519-522
- Second primary tumors in patients with cutaneous malignant melanoma.Cancer. 1999; 86: 2014-2020
- A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors.Cancer. 2003; 97: 639-643
- Radiation dose as a risk factor for malignant melanoma following childhood cancer.Eur J Cancer. 2003; 39: 2379-2386
- Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ.Int J Cancer. 1999; 83: 314-317
- Johnson C.H. SEER program coding and staging manual 2004, revision 1. NIH publication No. 04-5581. National Cancer Institute, Bethesda (MD)2004
- Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975-2001.Cancer. 2006; 107: 1162-1171
- Homozygous deletions within human chromosome band 9p21 in melanoma.Proc Nat Acad Sci. 1992; 89: 10557-10561
- Abnormalities of the short arm of chromosome 9 with partial loss of materials in hematological disorders.Leukemia. 1987; 1: 541-548
National Comprehensive Cancer Network. Melanoma: clinical practice guidelines in oncology. Available from: URL: http://www.nccn.org. Accessed March 23, 2011.
- Follow-up in patients with localized primary cutaneous melanoma.Lancet Oncol. 2005; 6: 608-621
- Follow-up recommendations for patients with American Joint Committee on Cancer stages I-III malignant melanoma.Cancer. 1999; 86: 2252-2258
- Multiple primary melanomas: implications for screening and follow-up programs for melanoma.Ann Surg Oncol. 1997; 4: 19-23
- Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.Int J Dermatol. 2007; 46: 575-577
- Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria.JAMA. 2004; 292: 2771-2776
Publication of this supplement to the JAAD was supported by the Division of Cancer Prevention and Control, Centers for Disease Control and Prevention (CDC) .
Conflicts of interest: None declared.
The opinions or views expressed in this supplement are those of the authors and do not necessarily reflect the opinions, recommendations, or official position of the journal editors or the Centers for Disease Control and Prevention.
User LicenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy